Neil A. Klompas, Chief Financial Officer at Zymeworks Inc. (ZYME), sold 1,425 shares at $34.95 ($50K) on 2021-03-10, disclosed to the SEC on 2021-03-12.
Scheduled sale ($50k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ZYME | SELL | 2020-12-11 | $1.3M | — | Filing → |
| ZYME | SELL | 2019-05-08 | $289K | — | Filing → |